Abstract
Safety is an absolute prerequisite for introducing any new therapy, and the need to monitor the consequences of administration of both vector and transgene to the fetus is particularly important. The unique features of fetal development that make it an attractive target for gene therapy, such as its immature immune system and rapidly dividing populations of stem cells, also mean that small perturbations in pregnancy can have significant short- and long-term consequences. Certain features of the viral vectors used, the product of the delivered gene, and sometimes the invasive techniques necessary to deliver the construct to the fetus in utero have the potential to do harm.
An important goal of prenatal gene therapy research is to develop clinically relevant techniques that could be applied to cure or ameliorate human disease in utero on large animal models such as sheep or nonhuman primates. Equally important is the use of these models to monitor for potential adverse effects of such interventions. These large animal models provide good representation of individual patient-based investigations. However, analyses that require defined genetic backgrounds, high throughput, defined variability and statistical analyses, e.g. for initial studies on teratogenic and oncogenic effects, are best performed on larger groups of small animals, in particular mice.
This chapter gives an overview of the potential adverse effects in relation to prenatal gene therapy and describes the techniques that can be used experimentally in a large animal model to monitor the potential adverse consequences of prenatal gene therapy, with relevance to clinical application. The sheep model is particularly useful to allow serial monitoring of fetal growth and well-being after delivery of prenatal gene therapy. It is also amenable to serially sampling using minimally invasive and clinically relevant techniques such as ultrasound-guided blood sampling. For more invasive long-term monitoring, we describe telemetric techniques to measure the haemodynamics of the mother or fetus, for example, that interferes minimally with normal animal behaviour. Implanted catheters can also be used for serial fetal blood sampling during gestation. Finally, we describe methods to monitor events around birth and long-term neonatal follow-up that are important when considering human translation of this therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tabor A, Philip J, Madsen M et al (1986) Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1:1287–1293
Alfirevic Z, Sundberg K, Brigham S (2003) Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database of Systematic Reviews CD003252
Weiner CP, Wenstrom KD, Sipes SL, Williamson RA (1991) Risk factors for cordocentesis and fetal intravascular transfusion. Am J Obstet Gynecol 165:1020–1025
Peckham CS, Martin JA, Marshall WC, Dudgeon JA (1979) Congenital rubella deafness: a preventable disease. Lancet 8110: 258–261
Preece PM, Pearl KN, Peckham CS (1984) Congenital cytomegalovirus infection. Arch Dis Child 59:1120–1126
Wenstrom KD, Andrews WW, Bowles NE et al (1998) Intrauterine viral infection at the time of second trimester genetic amniocentesis. Obstet Gynaecol 92:420–424
Dodic M, May CN, Wintour EM, Coghlan JP (1998) An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci 94:149–155
Schellenberg JC, Liggins GC (1987) New approaches to hormonal acceleration of fetal lung maturation. J Perinat Med 15:447–452
Barker DJ, Osmond C, Simmonds SJ, Wield GA (1993) The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 306:422–426
Miller SL, Loose JM, Jenkin G, Wallace EM (2008) The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus. Am J Obstet Gynaecol 102:e1–e7
David AL, Torondel B, Zachary I et al (2008) Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther 15:1344–1350
Porada CD, Park PJ, Tellez J et al (2005) Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero. Mol Ther 12:754–762
Heikkilä A, Hiltunen MO, Turunen MP et al (2001) Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes. Gene Ther 8:784–788
MacCalman CD, Furth EE, Omigbodun A et al (1996) Transduction of human trophoblast cells by recombinant adenoviruses is differentiation dependent. Biol Reprod 54: 682–691
Parry S, Holder J, Strauss JR (1997) Mechanisms of trophoblast-virus interaction. J Reprod Immunol 37:25–34
Koi H, Zhang J, Makrigiannakis A et al (2001) Differential expression of the coxsackievirus and adenovirus receptor regulates adenovirus infection of the placenta. Biol Reprod 64:1001–1009
Bedrosian JC, Gratton MA, Brigande JV et al (2006) In vivo delivery of recombinant viruses to the fetal murine cochlea: transduction characteristics and long-term effects on auditory function. Mol Ther 14:328–335
Brown AS, Derkits EJ (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167:261–280
Themis M, Waddington SN, Schmidt M et al (2005) Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 12: 763–771
Wong LF, Goodhead L, Prat C et al (2006) Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum Gene Ther 17:1–9
David AL, Peebles D (2007) Gene therapy for the fetus: is there a future? Best Pract Res Clin Obstet Gynaecol 22:203–218
Barbera A, Jones OW, Zerbe GW et al (1995) Early ultrasonographic detection of fetal growth retardation in an ovine model of placental insufficiency. Am J Obstet Gynecol 173:1071–1074
Kelly RW, Newnham JP (1989) Estimation of gestational age in Merino ewes by ultrasound measurement of fetal head size. Aust J Agr Res 40:1293–1299
Carr DJ, Aitken RP, Milne JS et al (2011) Ultrasonographic assessment of growth and estimation of birthweight in late gestation fetal sheep. Ultrasound Med Biol 37:1588–1595
Jeanty P, Dramaix-Wilmet M, Elkhazen N et al (1982) Measurements of fetal kidney growth on ultrasound. Radiology 144:159–162
Abi-Nader K, Mehta V, Wigley V et al (2009) Doppler ultrasonography for the noninvasive measurement of uterine artery volume blood flow through gestation in the pregnant sheep. Reprod Sci 17:13–19
Newnham JP, Kelly RW, Boyne P, Reid SE (1989) Ultrasound guided blood sampling from fetal sheep. Aust J Agr Res 40:401–407
Henderson DC (1990) The veterinary book for sheep farmers. Farming Press, Ipswich
Wallace JM, Bourke DA, Aitken RP et al (2002) Blood flows and nutrient uptakes in growth-restricted pregnancies induced by overnourishing adolescent sheep. Am J Physiol Regul Integr Comp Physiol 282:R1027–R1036
Macrae JC, Bruce LA, Hovell DFD et al (1991) Influence of protein nutrition on the response of growing lambs to exogenous bovine growth hormone. J Endocrinol 130:53–61
Dickerson KS, Newhouse VL, Tortoli P, Guidi G (1993) Comparison of conventional and transverse Doppler sonograms. J Ultrasound Med 12:497–506
Abi-Nader K, Mehta V, Shaw SWS et al (2010) Telemetric monitoring of fetal blood pressure and heart rate in the freely moving pregnant sheep: A feasibility study. Lab Anim Sci 45:50–54
Wallace JM, Luther JS, Milne JS et al (2006) Nutritional modulation of adolescent pregnancy outcome – a review. Placenta 27(Suppl A):S61–S68
Logan EF, Foster WH, Irwin D (1978) A note on bovine colostrum as an alternative source of immunoglobulins for lambs. Anim Prod 26:93–96
Jubb KVF, Kennedy PC, Palmer N (1993) Pathology of domestic animals. Academic, London
Meyer DJ, Harvey JW (1998) (Meyer DJ and Harvey JW, Eds.) Veterinary laboratory medicine – interpretation and diagnosis. WB Saunders Company, Philadelphia, pp 157–186
Kaneko JJ, Harvey JW, Bruss M (1997) Clinical biochemistry of domestic animals. Academic, San Diego
West HJ (1987) Changes in the concentrations of bile acids in the plasma of sheep with liver damage. Res Vet Sci 43:243–248
Anwer MS, Engelking LR, Gronwall R, Klentz RD (1976) Plasma bile acid elevation following carbon tetrachloride induced liver damage in dogs, sheep, calves and ponies. Res Vet Sci 20:127–130
Sutherland RJ, Deol HS, Hood PJ (1992) Changes in plasma bile acids, plasma amino acids, and hepatic enzyme pools as indices of functional impairment in liver-damaged sheep. Vet Clin Pathol 21:51–55
Hardy KJ, Hoffman NE, Mihaly G et al (1980) Bile acid metabolism in fetal sheep; perinatal changes in the bile acid pool. J Physiol 309:1–11
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC.
About this protocol
Cite this protocol
Mehta, V. et al. (2012). Monitoring for Potential Adverse Effects of Prenatal Gene Therapy: Use of Large Animal Models with Relevance to Human Application. In: Coutelle, C., Waddington, S. (eds) Prenatal Gene Therapy. Methods in Molecular Biology, vol 891. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-873-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-61779-873-3_14
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-872-6
Online ISBN: 978-1-61779-873-3
eBook Packages: Springer Protocols